CVS Health Co. (NYSE:CVS) Shares Purchased by Douglas Lane & Associates LLC

Douglas Lane & Associates LLC grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 1.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 702,663 shares of the pharmacy operator's stock after buying an additional 12,567 shares during the period. Douglas Lane & Associates LLC owned 0.06% of CVS Health worth $47,605,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health in the fourth quarter valued at $29,000. McIlrath & Eck LLC increased its holdings in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Financial Perspectives Inc increased its holdings in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares during the period. Finally, Compass Planning Associates Inc purchased a new position in shares of CVS Health in the fourth quarter worth about $37,000. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CVS shares. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Piper Sandler raised their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Robert W. Baird raised their price objective on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Truist Financial raised their price objective on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Finally, Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Stock Performance

NYSE CVS traded down $0.62 during trading hours on Thursday, hitting $62.95. 3,542,804 shares of the stock were exchanged, compared to its average volume of 11,095,984. The company has a market cap of $79.64 billion, a price-to-earnings ratio of 17.20, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The stock has a 50-day moving average of $65.39 and a 200 day moving average of $59.79. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.31 earnings per share. As a group, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.23%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.